Erythropoietin, uncertainty principle and cancer related anaemia.
Interesting analysis -additonal evidence supporting what has now become the standard practice in the oncology community. – Patricia Ford
Tag: CHEMOTHERAPY-INDUCED ANEMIA
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales.
This helpful article offers increased understanding and ability to utilize the functional assessment of cancer therapy (FACT) scale. – Patricia Ford
The clinical value of erythropoietin in patients with cancer.
This is a good review of cancer- and chemotherapy-related anemia and its treatment with epoetin alfa. However, the review seems a bit negative regarding epoetin relative to blood transfusion when […]
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Published this month in Blood and the Journal of Clinical Oncology are the much discussed and debated guidelines of a blue ribbon panel on the evidence-based use of erythropoietin in […]